+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Substitution of carboxyl tail of bovine dopamine transporter for human dopamine transporter attenuates substrate transport and cocaine binding in human dopamine transporter



Substitution of carboxyl tail of bovine dopamine transporter for human dopamine transporter attenuates substrate transport and cocaine binding in human dopamine transporter



Society for Neuroscience Abstracts 23(1-2): 407




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 033567354

Download citation: RISBibTeXText


Related references

Substrate transport and cocaine binding of human dopamine transporter is reduced by substitution of carboxyl tail with that of bovine dopamine transporter. Neuroreport 8(11): 2591-2594, 1997

Species differences in functions of dopamine transporter: Paucity of MPP+ uptake and cocaine binding in bovine dopamine transporter. Neuroscience Letters 214(2-3): 199-201, 1996

The dopamine transporter carboxyl-terminal tail. Truncation/substitution mutants selectively confer high affinity dopamine uptake while attenuating recognition of the ligand binding domain. Journal of Biological Chemistry 271(34): 20885-20894, 1996

The human dopamine transporter Functional consequences of carboxyl tail truncation/substitution. Society for Neuroscience Abstracts 21(1-3): 374, 1995

Mutation of tyrosine 470 of human dopamine transporter is critical for HIV-1 Tat-induced inhibition of dopamine transport and transporter conformational transitions. Journal of Neuroimmune Pharmacology 8(4): 975-987, 2014

Multisubtrate mechanism for the inward transport of dopamine by the human dopamine transporter expressed in HEK cells and its inhibition by cocaine. Synapse 33(3): 230-238, 1999

Restoration of cocaine stimulation and reward by reintroducing wild type dopamine transporter in adult knock-in mice with a cocaine-insensitive dopamine transporter. Neuropharmacology 86: 31-37, 2015

Dopamine uptake and cocaine binding mechanisms: the involvement of charged amino acids from the transmembrane domains of the human dopamine transporter. European Journal of Pharmacology 538(1-3): 43-47, 2006

Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Molecular Pharmacology 47(2): 368-373, 1995

Dopamine transporter mutants, small molecules, and approaches to cocaine antagonist/dopamine transporter disinhibitor development. Methods in Enzymology 296: 456-465, 1998

A dopamine transporter deletion mutant of the second extracellular loop affects dopamine transport and cocaine binding differentially. Society for Neuroscience Abstracts 21(1-3): 782, 1995

Dopamine D1, D2, D3 receptors, vesicular monoamine transporter type-2 (VMAT2) and dopamine transporter (DAT) densities in aged human brain. Plos One 7(11): E49483, 2013

Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Annals of Neurology 40(3): 428-439, 1996

Dopamine transporter phosphorylation site threonine 53 is stimulated by amphetamines and regulates dopamine transport, efflux, and cocaine analog binding. Journal of Biological Chemistry 292(46): 19066-19075, 2017

Role of valine at position 152 for the substrate transport and cocaine binding of dopamine transporter. Society for Neuroscience Abstracts 25(1-2): 160, 1999